Dementia

Dementia Policy in Japan

As average life expectancies grow longer, it becomes increasingly necessary for society to face issues that arise in aging populations. Dementia is a representative example of these issues. An estimated 46,086,000 people live with dementia worldwide today and their number is projected to increase to 74,070,000 people by 2030. Early-onset dementia must also be addressed.

Currently, there are no drugs for directly treating the primary diseases causing dementia such as Alzheimer’s disease. The development of new drugs alone, however, is insufficient. Society must be reconstructed in a way that enables people to effectively cope with the urgent issue of dementia on a global scale.


From the Enforcement of “Long-term Care Insurance Act” in 2000 to the “Comprehensive Strategy to Accelerate Dementia Measures” (New Orange Plan) in 2015

“Comprehensive Strategy to Accelerate Dementia Measures” for the purpose of the development towards a dementia-friendly community

Activities related to dementia measures undertaken by the Health and Global Policy Institute

In the recent years, HGPI has focused on research and advocacy for dementia measures. As the country in which population aging has advanced the most, dementia is a critical issue for Japan. Countries that will soon face population aging will face the issues that Japan is currently facing. We believe that in order to build a society that enables better living with dementia, it is crucial for multi-stakeholders to collaborate in building a platform in each field to seek solutions to issues related to aging. We are moving forward in a central role as a driver of global cooperation and we are working to deepen bonds with people with dementia and their families.



Research and policy recommendations to propose the best possible way to establish International PPP model that promote dementia research in an effective and efficient manner (Funded by Japan Agency for Medical Research and Development (AMED) )

Collaboration with the World Dementia Council (WDC) and other organizations

Implementation of dementia related events, meetings, and the Diet Study Group

Movie "The Importance of Measures against Dementia"


Project Team

  • Mariko Oyamada (COO, HGPI)
  • Shunichiro Kurita (Senior Associate, HGPI)
  • Yoshiki Niimi (Research Associate, Department of Neurology, Fujita Health University)
    (In no particular order)